<DOC>
	<DOC>NCT00180908</DOC>
	<brief_summary>The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.</brief_summary>
	<brief_title>Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>non metastatic limb osteosarcoma, age less than 20 years, biopsy proven highgrade osteosarcoma, no previous treatment, no contraindication to chemotherapy no previous malignancy, Written informed consent. juxtacortical sarcoma and microcellular anaplastic sarcoma, previous anticancer treatment contraindication to chemotherapy previous malignancy,</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Osteosarcoma</keyword>
</DOC>